An Analytical Reference Standard
Related Products
Active Metabolite(s)
3802010α-hydroxy-exo-THC 3802210α-hydroxy-Δ8-THC 3635311-hydroxy-9(R)-Hexahydrocannabinol 4412811-hydroxy-9(R)-Hexahydrocannabinol (exempt preparation) 3635411-hydroxy-9(S)-Hexahydrocannabinol 4412911-hydroxy-9(S)-Hexahydrocannabinol (exempt preparation) 399729α,10α-epoxy Hexahydrocannabinol 446109α,10α-epoxy Hexahydrocannabinol (exempt preparation) 446929α,10α-epoxy Hexahydrocannabinol (exempt preparation)
Certified Reference Material(s)
42138Δ9-THC (Alt. Batch CRM) ISO60157Δ9-THC (CRM) 43003Δ9-THC (CRM) 45655Δ9-THC (CRM)
Isomer(s)
9003416(+)-Cannabidiol 38947(+)-cis-Cannabidiol 35329(+)-Δ8-THC 33453(+)-Δ9-THC 34628(+)-Δ9-THC (exempt preparation) 26252(±)-Cannabichromene 41376(±)-Cannabichromene (Alt. Batch CRM) ISO60163(±)-Cannabichromene (CRM) 9002438(±)-Cannabicyclol42627(±)-Cannabicyclol (Alt. Batch CRM) 22036(±)-Cannabicyclol (CRM) 9003741(±)-Cannabidiol 27074(±)-cis-Δ9-THC 42464(±)-cis-Δ9-THC (CRM) 9003740(±)-Δ9-THC 34629(±)-Δ9-THC (exempt preparation) 41814(6aR,9R)-Δ10-THC (Alt. Batch CRM) 42625(6aR,9S)-Δ10-THC (Alt. Batch CRM) 37046(9,10a)-anti-Δ6a,7-THC 41297(9,10a)-anti-Δ6a,7-THC (exempt preparation) 37047(9,10a)-syn-Δ6a,7-THC 376348α-hydroxy-Δ9-THC 397938α-hydroxy-Δ9-THC (exempt preparation) 426299(R)-Δ6a,10a-THC (Alt. Batch CRM) 330139(R)-Δ6a,10a-THC (CRM) 340769(R)-Δ7-THC 391879(R)-Δ7-THC (CRM) 421419(S)-Δ6a,10a-THC (Alt. Batch CRM) 330149(S)-Δ6a,10a-THC (CRM) 340779(S)-Δ7-THC 10004259Abnormal Cannabidiol 37475Cannabicitran 21295Cannabicitran (CRM) 90080Cannabidiol 41217Cannabidiol (Alt. Batch CRM) ISO60156Cannabidiol (CRM) 41216exo-THC (Alt. Batch CRM) 36898exo-THC (CRM) 33863Δ4(8)-iso-THC 39955Δ4(8)-iso-THC (CRM) 43198Δ8-cis-iso-THC 33864Δ8-iso-THC 39000Δ8-iso-THC (CRM) 14042Δ8-THC 41193Δ8-THC (Alt. Batch CRM) ISO60158Δ8-THC (CRM)
Labeled Version(s)
19332Δ9-THC-d3 (CRM) 41210Δ9-THC-d3 (CRM) 34918Δ9-THC-d9 (CRM) 45656Δ9-THC-d9 (CRM)
Metabolite(s)
21667(±)-11-hydroxy-Δ9-THC (CRM) 41185(±)-11-hydroxy-Δ9-THC (CRM) 20754(±)-11-nor-9-carboxy-Δ9-THC (CRM) 41286(±)-11-nor-9-carboxy-Δ9-THC (CRM) 14239(−)-11-hydroxy-Δ9-THC 40600(−)-11-nor-9-carboxy-Δ9-THC (CRM) 427448-oxo-Δ9-THC 376358β-hydroxy-Δ9-THC 397948β-hydroxy-Δ9-THC (exempt preparation) 420239β,10β-epoxy Hexahydrocannabinol 446079β,10β-epoxy Hexahydrocannabinol (exempt preparation) 446959β,10β-epoxy Hexahydrocannabinol (exempt preparation) 39623Δ9-THC Glucuronide
Reference Material(s)
9003771Δ9-THC (solution)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Δ9-THC

Item No. 12068

Restricted Product (Schedule I)
Product Insert (PDF)GC-MS (PDF)Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • Dronabinol
  • NSC 134454
  • Δ9-Tetrahydrocannabinol
Technical Information
Formal Name
6aR,7,8,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
CAS Number
1972-08-3
Molecular Formula
C21H30O2
Formula Weight
314.5
Purity
≥95%
Formulation
A 50 mg/ml solution in acetonitrile
Solubility(Learn about Variance in Solubility)
Acetonitrile: 50 mg/mlDMF: 50 mg/mlDMF:PBS (pH 7.2)(1:3): 250 µg/mlDMSO: 60 mg/mlEthanol: 35 mg/mlMethanol: 30 mg/ml
SMILES
CC1=C[C@]2([H])[C@@](C(C)(C)OC3=C2C(O)=CC(CCCCC)=C3)([H])CC1
InChi Code
InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1
InChi Key
CYQFCXCEBYINGO-IAGOWNOFSA-N
Regulatory Information
DEA Schedule
I
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $71

    Add

    10 mg

    $127

    Add

    50 mg

    $388

    Add
    Cayman Chemical
    Explore All Cannabis Testing Resources
    Fit-for-Purpose CRMs & Analytical Standards
    • Major & minor phytocannabinoids
    • Novel cannabinoids
    • Terpenes & flavonoids
    • Pesticides, mycotoxins, & residual solvents
    LEARN MORE
    Product Description

    Δ9-THC (Item No. 12068) is an analytical reference standard categorized as a cannabinoid.1,2 It is psychoactive and has diverse effects on perception, cognition, and pain sensitivity.3 Δ9-THC is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg. Med. Chem. Lett. 16(20), 5432-5435 (2006).

    2. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6(8), 635-664 (1999).

    3. Grotenhermen, F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42(4), 327-360 (2003).

    Product Citations

    Mercier, G., Mohamed, K.A., Zagzoog, A., et al. In vitro pharmacological activity of twenty-eight synthetic cannabinoid receptor agonists at the type 1 and 2 cannabinoid receptors. Neurochem. Int. 190, 106039 (2025).

    Janssens, L.K., Van Uytfanghe, K., Williams, J.B., et al. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays—and how this matters for the harm potential of seized drugs. Arch. Toxicol. (2024).

    Huff, H.C., Vasan, A., Roy, P., et al. Differential interactions of selected phytocannabinoids with human CYP2D6 polymorphisms. Biochemistry (2021).

    Cairns, E.A., Szczesniak, A.-M., Straiker, A.J., et al. The in vivo effects of the CB1-positive allosteric modulator GAT229 on intraocular pressure in ocular normotensive and hypertensive mice. J. Ocul. Pharmacol. Ther. 33(8), 582-590 (2017).

    Merrick, J., Lane, B., Sebree, T., et al. Identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid. Cannabis Cannabinoid Res. 1.1, 102-112 (2016).